已核实 DOI PubMed 相关产品: 8

Immunological gadolinium-doped mesoporous carbon nanoparticles for tumor-targeted MRI and photothermal-immune co-therapy

Journal 2023 · IF 7 · 11(26): 6147-6158 · 发表于 2023 年 6 月 13 日
作者: Xiaoxi Song,Chun Zhang,Mengyuan Xing,Chunyan He,Dongxu Wang,Lijuan Chong,Xiuli Zhang,Minghui Chen,Jingjing Li
阅读全文 在 PubMed 查看

摘要

Photothermal therapy (PTT) is an effective and well-documented approach to thermally ablate tumors. However, the side effect of distal metastasis and recurrence limit its further expansion. At the same time as PTT was developed, the employment of imaging to monitor the treatment of tumors also became meaningful. Herein, as a proof of concept, gadolinium-doped mesoporous carbon nanoparticles (Gd-MCNs) were prepared as nanocarriers, MRI contrast agents, and PTT agents by a one-step hard template method, which realized Gd doping and carbon filling simultaneously, while retaining enough pore space for drug loading. After loading the immune adjuvant, R837, and the coating of tumor extracellular vesicle, the obtained biomimetic nanoparticles (EV@Gd-MCNs-R837) not only allowed tumor MRI, but also inhibited the primary tumor and its metastasis with long-term immune memory in vivo. This study provides proof for the potential of Gd-MCNs-based biomimetic nanoparticles for targeted PTT/immune-enhanced synergistic theranostic of tumors.

本研究中使用的阿拉丁产品

8 款产品在本文中被引用